Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia

NCT00231335 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: escitalopram

Sponsor

Emory University

Collaborators

[object Object]